Coamorphous Active Pharmaceutical Ingredient–Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability-Reference-Cited by-同舟云学术

Coamorphous Active Pharmaceutical Ingredient–Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability

Published:2018-01 Issue:1 Volume:107 Page:5-17
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Newman Ann,Reutzel-Edens Susan M.,Zografi George

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference127 articles.

1. Introduction to amorphous solid dispersions;Zografi,2015

2. Pharmaceutical cocrystals: along the path to improved medicines;Duggirala;Chem Commun,2016

3. Recent advances in co-amorphous formulations;Dengale;Adv Drug Deliv Rev,2016

4. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions;Ghebremeskel;Pharm Res,2006

5. The role of acidifiers in solid dispersions and physical mixtures;Tran;Int J Pharm,2010

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization;International Journal of Pharmaceutics;2024-10

2. Bosentan monohydrate and sildenafil base as two companions in enabling formulations;International Journal of Pharmaceutics;2024-08

3. Structural Features of the Glassy State and Their Impact on the Solid-State Properties of Organic Molecules in Pharmaceutical Systems;Journal of Pharmaceutical Sciences;2024-05

4. Multicomponent Amorphous Solid Forms of Telmisartan: Insights into Mechanochemical Activation and Physicochemical Attributes;AAPS PharmSciTech;2024-04-11

5. A review on advancement of cocrystallization approach and a brief on screening, formulation and characterization of the same;Heliyon;2024-04